Yutian Cao
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Multi-omics and spatial proteomic profiling reveal novel AGXT2- PYCR3- macrophages and their phenotypes in metabolic dysfunction-associated steatotic liver disease.
Journal: Genome medicine
Published: February 21, 2026
Myricetin stabilizes PINK1 to activate mitophagy and ameliorate metabolic dysfunction-associated steatotic liver disease.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 16, 2025
Hepatic HMGCS2-derived β-hydroxybutyrate attenuates hippocampal insulin resistance and neuroinflammation to promote MASLD-induced cognitive function.
Journal: Communications biology
Published: June 25, 2025
Identification of CACNB1 protein as an actionable therapeutic target for hepatocellular carcinoma via metabolic dysfunction analysis in liver diseases: An integrated bioinformatics and machine learning approach for precise therapy.
Journal: International journal of biological macromolecules
Published: October 03, 2024
The causal relationship between gut microbiota and alopecia areata: a Mendelian randomization analysis.
Journal: Frontiers in microbiology
Published: May 12, 2024
Institutional Nomogram for Estimating Risk of Metabolic Associated Fatty Liver Disease (MAFLD).
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 19, 2024
The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.
Journal: Frontiers in endocrinology
Published: November 08, 2023
Duodenal Mucosa: A New Target for the Treatment of Type 2 Diabetes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: July 15, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026